Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.ijantimicag.2021.106324 http://scihub22266oqcxt.onion/10.1016/j.ijantimicag.2021.106324 33746045!7972869!33746045     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Int+J+Antimicrob+Agents 2021 ; 57 (4): 106324 Nephropedia Template TP {{tp|p=33746045|t=2021. Increased antimicrobial resistance during the COVID-19 pandemic |pdf=|usr=}}{{33746045}} gab.com Text Increased antimicrobial resistance during the COVID-19 pandemic JO: Int J Antimicrob Agents http://www.kidney.de/pget.php?&tw=1&pmid=33746045 #FOAvip In addition to SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection itself, an increase in the incidence of antimicrobial resistance poses collateral damage to the current status of the COVID-19 (coronavirus disease 2019) pandemic. There has been a rapid increase in multidrug-resistant organisms (MDROs), including extended-spectrum beta-lactamase (ESBL)-producing Klebsiella pneumoniae, carbapenem-resistant New Delhi metallo-beta-lactamase (NDM)-producing Enterobacterales, Acinetobacter baumannii, methicillin-resistant Staphylococcus aureus (MRSA), pan-echinocandin-resistant Candida glabrata and multi-triazole-resistant Aspergillus fumigatus. The cause is multifactorial and is particularly related to high rates of antimicrobial agent utilisation in COVID-19 patients with a relatively low rate of co- or secondary infection. Appropriate prescription and optimised use of antimicrobials according to the principles of antimicrobial stewardship as well as quality diagnosis and aggressive infection control measures may help prevent the occurrence of MDROs during this pandemic. Twit Text FOAVip Increased antimicrobial resistance during the COVID-19 pandemic ????Int J Antimicrob Agents http://www.kidney.de/pget.php?&tw=1&pmid=33746045 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33746045 #FOAvip English Wikipedia <ref>{{Cite pmid|33746045}}</ref> Increased antimicrobial resistance during the COVID-19 pandemic #MMPMID33746045 Lai CC; Chen SY; Ko WC; Hsueh PR Int J Antimicrob Agents 2021[Apr]; 57 (4): 106324 PMID33746045show ga In addition to SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection itself, an increase in the incidence of antimicrobial resistance poses collateral damage to the current status of the COVID-19 (coronavirus disease 2019) pandemic. There has been a rapid increase in multidrug-resistant organisms (MDROs), including extended-spectrum beta-lactamase (ESBL)-producing Klebsiella pneumoniae, carbapenem-resistant New Delhi metallo-beta-lactamase (NDM)-producing Enterobacterales, Acinetobacter baumannii, methicillin-resistant Staphylococcus aureus (MRSA), pan-echinocandin-resistant Candida glabrata and multi-triazole-resistant Aspergillus fumigatus. The cause is multifactorial and is particularly related to high rates of antimicrobial agent utilisation in COVID-19 patients with a relatively low rate of co- or secondary infection. Appropriate prescription and optimised use of antimicrobials according to the principles of antimicrobial stewardship as well as quality diagnosis and aggressive infection control measures may help prevent the occurrence of MDROs during this pandemic. |*Drug Resistance, Microbial[MESH] |Anti-Bacterial Agents/pharmacology/*therapeutic use[MESH] |Antimicrobial Stewardship[MESH] |Bacteria/drug effects[MESH] |Bacterial Infections/*complications/drug therapy/epidemiology[MESH] |COVID-19/*complications/*epidemiology[MESH] |Coinfection/*drug therapy/epidemiology[MESH] |Drug Utilization[MESH] |Fungi/drug effects[MESH] |Humans[MESH] |Incidence[MESH] |Mycoses/*complications/drug therapy/epidemiology[MESH]Increased antimicrobial resistance during the COVID-19 pandemic (epmc).pdf DeepDyve Pubget Overpricing